Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
2.930
+0.030 (1.03%)
Nov 21, 2024, 4:00 PM EST - Market closed
Zura Bio Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$15.80
Upside
+439.25%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +70.65% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +70.65% | Nov 11, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +309.56% | Nov 8, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $15 | Buy | Initiates | $15 | +411.95% | Nov 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +70.65% | Oct 21, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 18, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $26 | Buy | Maintains | $26 | +787.37% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $5 | Hold | Initiates | $5 | +70.65% | Sep 5, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 12, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 → $21 | Buy | Maintains | $16 → $21 | +616.72% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $26 | Buy | Initiates | $26 | +787.37% | May 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 → $16 | Buy | Reiterates | $17 → $16 | +446.08% | Apr 1, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +241.30% | Oct 10, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +480.20% | Aug 25, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.